Polygenic Risk Score Combined with Transcranial Sonography Refines Parkinson's Disease Risk Prediction

被引:0
|
作者
Kals, Mart [1 ]
Reigo, Anu [1 ]
Teder-Laving, Maris [1 ]
Vaht, Mariliis [1 ]
Nikopensius, Tiit [1 ]
Metspalu, Andres [1 ,2 ]
Toomsoo, Toomas [3 ,4 ]
机构
[1] Univ Tartu, Inst Genom, Estonian Genome Ctr, Tartu, Estonia
[2] Univ Tartu, Inst Mol & Cell Biol, Tartu, Estonia
[3] Confido Med Ctr, Veerenni 51, EE-10138 Tallinn, Estonia
[4] Tallinn Univ, Sch Nat Sci & Hlth, Tallinn, Estonia
关键词
Parkinson's disease; polygenic risk score; substantia nigra hyperechogenicity; transcranial sonography; SUBSTANTIA-NIGRA HYPERECHOGENICITY; RESEARCH CRITERIA; IDENTIFICATION; METAANALYSIS; ASSOCIATION; DISORDER; MIDBRAIN; FEATURES; MARKERS; SIGNS;
D O I
10.1002/mdc3.70011
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Dopaminergic neuron depletion in the substantia nigra (SN) and the pathological aggregation of alpha-synuclein are the neuropathological hallmarks of Parkinson's disease (PD). Objectives : This study aimed to investigate the association between the polygenic risk score for PD (PD-PRS) and transcranial sonography (TCS)-measured SN hyperechogenicity to enhance the accuracy of PD susceptibility prediction. Methods : PD-PRSs were calculated for over 41,000 Estonian Biobank participants age 55+ years without a PD diagnosis. Participants in the highest and lowest PD-PRS percentiles (n = 222) underwent TCS measurements and Sniffin' sticks olfactory testing. A multivariable logistic regression model was used to examine the associations between PD-PRS, risk and prodromal markers, and SN hyperechogenicity. Results : Data from 204 participants with TCS measurements were analyzed, including 107 individuals in the high-risk PD-PRS group and 97 in the low-risk PD-PRS group. Incorporating PD-PRS group assignment improved the explained variance in SN hyperechogenicity from 17.2% to 31.9%. Participants in the low-risk PD-PRS group had 0.16 times lower odds (95% confidence interval (CI) = 0.07-0.35, P < 0.001) of developing SN hyperechogenicity compared to high-risk PD-PRS individuals. Each unit increase in the Sniffin' sticks olfactory test score was significantly associated with reduced odds of SN hyperechogenicity (adjusted odds ratio = 0.60, 95% CI = 0.47-0.78, P = 0.002). Conclusions : Our findings indicate that TCS-measured SN hyperechogenicity is associated with PD-PRS and olfactory impairment. This combined assessment may improve early diagnosis of prodromal PD by pinpointing individuals at increased risk.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Association of the Polygenic Risk Score with the Incidence Risk of Parkinson’s Disease and Cerebrospinal Fluid α-Synuclein in a Chinese Cohort
    Wei-Wei Li
    Dong-Yu Fan
    Ying-Ying Shen
    Fa-Ying Zhou
    Yang Chen
    Ye-Ran Wang
    Heng Yang
    Jing Mei
    Ling Li
    Zhi-Qiang Xu
    Yan-Jiang Wang
    Neurotoxicity Research, 2019, 36 : 515 - 522
  • [22] Polygenic Risk Score: An Application to the Prediction of Asthma Risk
    Ricard, Jasmin
    Li, Zhonglin
    Theriault, Sebastien
    Bosse, Yohan
    Eslami, Aida
    GENETIC EPIDEMIOLOGY, 2021, 45 (07) : 785 - 785
  • [23] A DIVERTICULAR DISEASE PREDICTION MODEL USING A POLYGENIC RISK SCORE
    Schaeffer, Henry D.
    Smelser, Diane T.
    Rao, H. Shanker
    Haley, Jeremy S.
    Long, Kevin
    Slipak, Sasha
    Carey, David
    Hoffman, Rebecca
    GASTROENTEROLOGY, 2022, 162 (07) : S1302 - S1303
  • [24] Association of the Polygenic Risk Score with the Incidence Risk of Parkinson's Disease and Cerebrospinal Fluid α-Synuclein in a Chinese Cohort
    Li, Wei-Wei
    Fan, Dong-Yu
    Shen, Ying-Ying
    Zhou, Fa-Ying
    Chen, Yang
    Wang, Ye-Ran
    Yang, Heng
    Mei, Jing
    Li, Ling
    Xu, Zhi-Qiang
    Wang, Yan-Jiang
    NEUROTOXICITY RESEARCH, 2019, 36 (03) : 515 - 522
  • [25] A Polygenic Risk Score for Prostate Cancer Risk Prediction
    Schaffer, Kerry R.
    Shi, Mingjian
    Shelley, John P.
    Tosoian, Jeffrey J.
    Kachuri, Linda
    Witte, John S.
    Mosley, Jonathan D.
    JAMA INTERNAL MEDICINE, 2023, 183 (04) : 386 - 388
  • [26] A polygenic risk score for multiple myeloma risk prediction
    Canzian, Federico
    Piredda, Chiara
    Macauda, Angelica
    Zawirska, Daria
    Andersen, Niels Frost
    Nagler, Arnon
    Zaucha, Jan Maciej
    Mazur, Grzegorz
    Dumontet, Charles
    Watek, Marzena
    Jamroziak, Krzysztof
    Sainz, Juan
    Varkonyi, Judit
    Butrym, Aleksandra
    Beider, Katia
    Abildgaard, Niels
    Lesueur, Fabienne
    Dudzinski, Marek
    Vangsted, Annette Juul
    Pelosini, Matteo
    Subocz, Edyta
    Petrini, Mario
    Buda, Gabriele
    Razny, Malgorzata
    Gemignani, Federica
    Marques, Herlander
    Orciuolo, Enrico
    Kadar, Katalin
    Jurczyszyn, Artur
    Druzd-Sitek, Agnieszka
    Vogel, Ulla
    Andersen, Vibeke
    Reis, Rui Manuel
    Suska, Anna
    Avet-Loiseau, Herve
    Kruszewski, Marcin
    Tomczak, Waldemar
    Rymko, Marcin
    Minvielle, Stephane
    Campa, Daniele
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2022, 30 (04) : 474 - 479
  • [27] A polygenic risk score for multiple myeloma risk prediction
    Federico Canzian
    Chiara Piredda
    Angelica Macauda
    Daria Zawirska
    Niels Frost Andersen
    Arnon Nagler
    Jan Maciej Zaucha
    Grzegorz Mazur
    Charles Dumontet
    Marzena Wątek
    Krzysztof Jamroziak
    Juan Sainz
    Judit Várkonyi
    Aleksandra Butrym
    Katia Beider
    Niels Abildgaard
    Fabienne Lesueur
    Marek Dudziński
    Annette Juul Vangsted
    Matteo Pelosini
    Edyta Subocz
    Mario Petrini
    Gabriele Buda
    Małgorzata Raźny
    Federica Gemignani
    Herlander Marques
    Enrico Orciuolo
    Katalin Kadar
    Artur Jurczyszyn
    Agnieszka Druzd-Sitek
    Ulla Vogel
    Vibeke Andersen
    Rui Manuel Reis
    Anna Suska
    Hervé Avet-Loiseau
    Marcin Kruszewski
    Waldemar Tomczak
    Marcin Rymko
    Stephane Minvielle
    Daniele Campa
    European Journal of Human Genetics, 2022, 30 : 474 - 479
  • [28] GenoRisk: A polygenic risk score for Alzheimer's disease
    Dickson, Samuel P.
    Hendrix, Suzanne B.
    Brown, Bruce L.
    Ridge, Perry G.
    Nicodemus-Johnson, Jessie
    Hardy, Marci L.
    McKeany, Allison M.
    Booth, Steven B.
    Fortna, Ryan R.
    Kauwe, John S. K.
    ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS, 2021, 7 (01)
  • [29] Combined effect of polygenic background and GBA pathogenic variants in Parkinson's disease risk
    Landoulsi, Z.
    Hassanin, E.
    Pachchek, S.
    Bobbili, D. B.
    May, P.
    MOVEMENT DISORDERS, 2023, 38 : S481 - S482
  • [30] Polygenic risk prediction and SNCA haplotype analysis in a Latino Parkinson's disease cohort
    Loesch, Douglas P.
    Horimoto, Andrea R. V. R.
    Sarihan, Elif Irem
    Inca-Martinez, Miguel
    Mason, Emily
    Cornejo-Olivas, Mario
    Torres, Luis
    Mazzetti, Pilar
    Cosentino, Carlos
    Sarapura-Castro, Elison
    Rivera-Valdivia, Andrea
    Medina, Angel C.
    Dieguez, Elena
    Raggio, Victor
    Lescano, Andres
    Tumas, Vitor
    Borges, Vanderci
    Ferraz, Henrique B.
    Rieder, Carlos R.
    Schumacher-Schuh, Artur
    Santos-Lobato, Bruno L.
    Velez-Pardo, Carlos
    Jimenez-Del-Rio, Marlene
    Lopera, Francisco
    Moreno, Sonia
    Chana-Cuevas, Pedro
    Fernandez, William
    Arboleda, Gonzalo
    Arboleda, Humberto
    Arboleda-Bustos, Carlos E.
    Yearout, Dora
    Zabetian, Cyrus P.
    Thornton, Timothy A.
    Mata, Ignacio F.
    O'Connor, Timothy D.
    PARKINSONISM & RELATED DISORDERS, 2022, 102 : 7 - 15